FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040132584> ?p ?o ?g. }

• W2040132584 endingPage "36" @default.
• W2040132584 startingPage "31" @default.
• W2040132584 abstract "BackgroundAlthough angiotensin receptor blockers (ARBs) are now one of the first-line drug classes for the management of hypertension, recommendations for the management of chronic heart failure (CHF) are limited. The supplemental benefit of angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial investigates whether an additive treatment with an ARB, olmesartan, reduces the mortality and morbidity in hypertensive patients with stable chronic heart failure.Methods and resultsThe SUPPORT trial is a prospective randomized open-label blinded endpoint study. Between October 2006 and March 2010, 1147 stable CHF patients treated with evidence-based medications were successfully randomized to either olmesartan or control group. In the olmesartan group, the ARB was initiated at the dose of 5.0–10 mg, and was then increased up to 40 mg/day, when possible. No ARBs were allowed in the control group. Primary outcome measure in the SUPPORT trial is the composite of all-cause death, non-fatal acute myocardial infarction, non-fatal stroke and hospital admission due to worsening heart failure. The participants will be followed for at least 3 years until March 2013.ConclusionsThe SUPPORT trial will elucidate the supplemental benefits of an ARB, olmesartan, in hypertensive patients with CHF." @default.
• W2040132584 created "2016-06-24" @default.
• W2040132584 creator A5012657143 @default.
• W2040132584 creator A5014883182 @default.
• W2040132584 creator A5015768658 @default.
• W2040132584 creator A5020197601 @default.
• W2040132584 creator A5021218765 @default.
• W2040132584 creator A5033891446 @default.
• W2040132584 creator A5040009028 @default.
• W2040132584 creator A5046553307 @default.
• W2040132584 date "2013-07-01" @default.
• W2040132584 modified "2023-10-06" @default.
• W2040132584 title "Supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial—Rationale and design" @default.
• W2040132584 cites W1966912437 @default.
• W2040132584 cites W1974365418 @default.
• W2040132584 cites W1978387124 @default.
• W2040132584 cites W1984973770 @default.
• W2040132584 cites W1995861586 @default.
• W2040132584 cites W1997224652 @default.
• W2040132584 cites W2008076845 @default.
• W2040132584 cites W2008935865 @default.
• W2040132584 cites W2009465892 @default.
• W2040132584 cites W2056893352 @default.
• W2040132584 cites W2066485730 @default.
• W2040132584 cites W2068519950 @default.
• W2040132584 cites W2075759443 @default.
• W2040132584 cites W2081283011 @default.
• W2040132584 cites W2083208628 @default.
• W2040132584 cites W2084694910 @default.
• W2040132584 cites W2089722923 @default.
• W2040132584 cites W2091716024 @default.
• W2040132584 cites W2098780362 @default.
• W2040132584 cites W2100166328 @default.
• W2040132584 cites W2101839496 @default.
• W2040132584 cites W2109712401 @default.
• W2040132584 cites W2127254785 @default.
• W2040132584 cites W2130426015 @default.
• W2040132584 cites W2136115956 @default.
• W2040132584 cites W2147084771 @default.
• W2040132584 cites W2155777324 @default.
• W2040132584 cites W2156121263 @default.
• W2040132584 cites W2160117042 @default.
• W2040132584 cites W2170020414 @default.
• W2040132584 cites W2329624119 @default.
• W2040132584 cites W3021063182 @default.
• W2040132584 doi "https://doi.org/10.1016/j.jjcc.2013.02.011" @default.
• W2040132584 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23769179" @default.
• W2040132584 hasPublicationYear "2013" @default.
• W2040132584 type Work @default.
• W2040132584 sameAs 2040132584 @default.
• W2040132584 citedByCount "14" @default.
• W2040132584 countsByYear W20401325842014 @default.
• W2040132584 countsByYear W20401325842015 @default.
• W2040132584 countsByYear W20401325842016 @default.
• W2040132584 countsByYear W20401325842017 @default.
• W2040132584 countsByYear W20401325842018 @default.
• W2040132584 countsByYear W20401325842019 @default.
• W2040132584 countsByYear W20401325842021 @default.
• W2040132584 crossrefType "journal-article" @default.
• W2040132584 hasAuthorship W2040132584A5012657143 @default.
• W2040132584 hasAuthorship W2040132584A5014883182 @default.
• W2040132584 hasAuthorship W2040132584A5015768658 @default.
• W2040132584 hasAuthorship W2040132584A5020197601 @default.
• W2040132584 hasAuthorship W2040132584A5021218765 @default.
• W2040132584 hasAuthorship W2040132584A5033891446 @default.
• W2040132584 hasAuthorship W2040132584A5040009028 @default.
• W2040132584 hasAuthorship W2040132584A5046553307 @default.
• W2040132584 hasBestOaLocation W20401325841 @default.
• W2040132584 hasConcept C104849204 @default.
• W2040132584 hasConcept C126322002 @default.
• W2040132584 hasConcept C127413603 @default.
• W2040132584 hasConcept C164705383 @default.
• W2040132584 hasConcept C168563851 @default.
• W2040132584 hasConcept C203092338 @default.
• W2040132584 hasConcept C2778198053 @default.
• W2040132584 hasConcept C2779716603 @default.
• W2040132584 hasConcept C2779766728 @default.
• W2040132584 hasConcept C2780645631 @default.
• W2040132584 hasConcept C2908929049 @default.
• W2040132584 hasConcept C500558357 @default.
• W2040132584 hasConcept C71924100 @default.
• W2040132584 hasConcept C78519656 @default.
• W2040132584 hasConcept C84393581 @default.
• W2040132584 hasConceptScore W2040132584C104849204 @default.
• W2040132584 hasConceptScore W2040132584C126322002 @default.
• W2040132584 hasConceptScore W2040132584C127413603 @default.
• W2040132584 hasConceptScore W2040132584C164705383 @default.
• W2040132584 hasConceptScore W2040132584C168563851 @default.
• W2040132584 hasConceptScore W2040132584C203092338 @default.
• W2040132584 hasConceptScore W2040132584C2778198053 @default.
• W2040132584 hasConceptScore W2040132584C2779716603 @default.
• W2040132584 hasConceptScore W2040132584C2779766728 @default.
• W2040132584 hasConceptScore W2040132584C2780645631 @default.
• W2040132584 hasConceptScore W2040132584C2908929049 @default.
• W2040132584 hasConceptScore W2040132584C500558357 @default.
• W2040132584 hasConceptScore W2040132584C71924100 @default.
• W2040132584 hasConceptScore W2040132584C78519656 @default.
• W2040132584 hasConceptScore W2040132584C84393581 @default.

• next